Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Biopharmaceutical Factors Influencing Drug Product Design: Overview01:22

Biopharmaceutical Factors Influencing Drug Product Design: Overview

Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry01:20

Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry

Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
In Vitro Drug Dissolution: Compendial Testing Models II01:09

In Vitro Drug Dissolution: Compendial Testing Models II

Various dissolution methods are utilized to assess a drug’s dissolution rate, including the flow-through cell, paddle-over-disk, cylinder, and reciprocating disk methods.The flow-through cell apparatus (USP (United States Pharmacopeia) method 4) comprises a reservoir for the dissolution medium and a pump that propels the medium through the cell containing the test sample. This method is crucial for assessing modified-release dosage forms with minimally soluble active ingredients, maintaining...
In Vitro Drug Dissolution: Compendial Testing Models I01:13

In Vitro Drug Dissolution: Compendial Testing Models I

Compendial dissolution methods are standardized procedures defined by pharmacopeias to evaluate the rate at which a drug dissolves in a specific medium. These methods ensure batch-to-batch consistency, enable quality control, and support the prediction of drug bioavailability. They are critical for both immediate and modified-release drug products.The apparatuses used for dissolution testing differ in their design and mechanical function, but all aim to simulate the physiological environment of...
Factors Influencing Drug Absorption: Pharmaceutical Parameters01:28

Factors Influencing Drug Absorption: Pharmaceutical Parameters

Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
Factors Affecting Drug Distribution: Miscellaneous Factors01:19

Factors Affecting Drug Distribution: Miscellaneous Factors

Drug distribution in the human body is a complex process influenced by various individual factors, including age, pregnancy, obesity, diet, body water composition, pH levels, and specific disease conditions.
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of a nnU-Net type automated clinical volumetric tumor segmentation tool for diffuse low-grade glioma follow-up.

Journal of neuroradiology = Journal de neuroradiologie·2023
Same author

Understanding Loss of Soluble High Molecular Weight Species during Filtration of Low Concentration Therapeutic Monoclonal Antibodies.

Journal of pharmaceutical sciences·2021
Same author

Quantifying the Vial-Capping Process: Reexamination Using Micro-Computed Tomography.

PDA journal of pharmaceutical science and technology·2019
Same author

Split-Cakes, Still Delicious.

PDA journal of pharmaceutical science and technology·2018
Same author

Quantifying the Vial Capping Process: Residual Seal Force and Container Closure Integrity.

PDA journal of pharmaceutical science and technology·2018
Same author

Impact of Vial Capping on Residual Seal Force and Container Closure Integrity.

PDA journal of pharmaceutical science and technology·2016

Related Experiment Video

Updated: Jun 2, 2026

The Quantification of Injectability by Mechanical Testing
04:46

The Quantification of Injectability by Mechanical Testing

Published on: May 13, 2020

Visualization Techniques for Assessing Design Factors That Affect the Interaction between Pharmaceutical Vials and

Philippe Lam, Al Stern

    PDA Journal of Pharmaceutical Science and Technology
    |April 20, 2011
    PubMed
    Summary

    New visualization techniques reveal stopper-vial fit in the critical flange area. This aids in designing robust primary packaging and screening components for better fit and seal integrity.

    More Related Videos

    A Workflow for Lipid Nanoparticle (LNP) Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models (SVEM)
    13:54

    A Workflow for Lipid Nanoparticle (LNP) Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models (SVEM)

    Published on: August 18, 2023

    An Open Source Technology Platform to Manufacture Hydrogel-Based 3D Culture Models in an Automated and Standardized Fashion
    08:29

    An Open Source Technology Platform to Manufacture Hydrogel-Based 3D Culture Models in an Automated and Standardized Fashion

    Published on: March 31, 2022

    Related Experiment Videos

    Last Updated: Jun 2, 2026

    The Quantification of Injectability by Mechanical Testing
    04:46

    The Quantification of Injectability by Mechanical Testing

    Published on: May 13, 2020

    A Workflow for Lipid Nanoparticle (LNP) Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models (SVEM)
    13:54

    A Workflow for Lipid Nanoparticle (LNP) Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models (SVEM)

    Published on: August 18, 2023

    An Open Source Technology Platform to Manufacture Hydrogel-Based 3D Culture Models in an Automated and Standardized Fashion
    08:29

    An Open Source Technology Platform to Manufacture Hydrogel-Based 3D Culture Models in an Automated and Standardized Fashion

    Published on: March 31, 2022

    Area of Science:

    • Pharmaceutical packaging
    • Materials science
    • Mechanical engineering

    Background:

    • The primary packaging seal between stoppers and vials is critical for drug product stability.
    • The flange area, where the initial seal forms, is often hidden and difficult to inspect.
    • Understanding component fit is essential for ensuring package integrity.

    Purpose of the Study:

    • To develop and present novel visualization techniques for assessing stopper-vial fit.
    • To identify critical design elements contributing to a robust primary package seal.
    • To enable early-stage component screening for improved packaging solutions.

    Main Methods:

    • Development of specialized visualization tools.
    • Application of techniques to analyze the flange area of stopper-vial systems.
    • Illustrative examples demonstrating technique utility.

    Main Results:

    • Successful visualization of the stopper-vial interface in the flange area.
    • Identification of key surfaces involved in initial seal formation.
    • Demonstration of how design elements impact seal robustness.

    Conclusions:

    • The developed visualization techniques provide critical insights into stopper-vial fit.
    • These methods facilitate the design of more reliable primary pharmaceutical packaging.
    • Component screening using these techniques can prevent the use of ill-fitting parts, improving overall quality.